评估单疗法环环酸盐与聚二硫酸盐对急性高血症的评估:一个队列研究
Divine Grewal1, Laurensia Urip1, Lisa T Hong1
1Loma Linda University School of Pharmacy, Loma Linda, CA, USA.
Hospital pharmacy
|November 15, 2024
概括
环环酸盐 (SZC) 和聚二硫酸盐 (SPS) 在急性高血症中表现出类似的有效性. SZC可以提供更快,更大的降低,在严重的情况下需要进一步调查.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 急性高血症是一种常见的临床问题,需要及时治疗.
- 聚二硫酸盐 (SPS) 是一种传统的治疗方法,但如环酸盐 (SZC) 等新药也可用.
- 对SZC和SPS之间对急性降低的单一治疗疗效的直接比较是有限的.
研究的目的:
- 为了比较单一治疗中环酸盐 (SZC) 与聚二硫酸盐 (SPS) 在降低急性高血症的住院成人患者的血清的有效性.
主要方法:
- 一个回顾性队列研究,包括101名急性高血症的住院成年患者.
- 患者接受SZC (n=51) 或SPS (n=50) 单一治疗.
- 主要结局:血清的正常化时间. 二次结局:治疗的必要性,在不同时间点达到血量正常,血清的变化与基线.
主要成果:
- 在SZC中,正常血的中位时间为14小时,在SPS中为17小时 (P=.26).
- 在80%的SZC患者和77%的SPS患者 (P=.56) 中,在24小时内实现了正常血量.
- 在大多数时间点,血清与SZC在数值上较低,在8小时观察到的统计学上显著的差异 (P=.005) 和从基线整体下降 (P=.026).
结论:
- 环环酸盐 (SZC) 单疗至少与聚硫酸盐 (SPS) 在治疗轻度急性高血症方面同样有效.
- 与SPS相比,SZC可能会提供与SPS相比,血清的更快,更明显的降低.
- 需要对严重高血症和定期水平监测进行进一步的研究,以充分阐明SZC的优势.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.2K
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
17.3K
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
461
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
461
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
911
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
911
